pimagedine has been researched along with Cardiovascular Diseases in 8 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Beheshti, F | 1 |
Hosseini, M | 1 |
Hashemzehi, M | 1 |
Hadipanah, MR | 1 |
Mahmoudabady, M | 1 |
Micans, P | 1 |
Pertynska-Marczewska, M | 1 |
Merhi, Z | 1 |
Kawakami, M | 1 |
Kuroki, M | 1 |
Aronson, D | 1 |
McEniery, CM | 1 |
Chan, V | 1 |
Hoey, A | 1 |
Brown, L | 1 |
Zhang, J | 1 |
Ren, S | 1 |
Shen, GX | 1 |
2 reviews available for pimagedine and Cardiovascular Diseases
Article | Year |
---|---|
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Topics: Cardiovascular Diseases; Cinnamates; Female; Glycation End Products, Advanced; Guanidines; Humans; M | 2015 |
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diab | 2002 |
1 trial available for pimagedine and Cardiovascular Diseases
Article | Year |
---|---|
Aortic wave velocity: a noninvasive method to measure the stiffness of arteries and the clinical results of supplements that appear to improve arterial stiffness.
Topics: Adult; Aged; Aging; Arginine; Cardiovascular Diseases; Carnosine; Dietary Supplements; Female; Glyca | 2013 |
5 other studies available for pimagedine and Cardiovascular Diseases
Article | Year |
---|---|
The Cardioprotective Effects of Aminoguanidine on Lipopolysaccharide Induced Inflammation in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotoxicity; Cardiovascular Diseases; Cardiovasc | 2020 |
Pharmacological prevention of cardiovascular aging--targeting the Maillard reaction.
Topics: Aging; Animals; Cardiovascular Diseases; Coronary Vessels; Elasticity; Glycation End Products, Advan | 2004 |
Novel therapeutic strategies for reducing arterial stiffness.
Topics: Arteries; Cardiovascular Agents; Cardiovascular Diseases; Glycation End Products, Advanced; Guanidin | 2006 |
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Topics: Action Potentials; Animals; Aorta, Thoracic; Cardiovascular Diseases; Collagen; Cross-Linking Reagen | 2006 |
Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.
Topics: Biomarkers; Blotting, Northern; Cardiovascular Diseases; Cells, Cultured; Diabetes Complications; Di | 2000 |